Cargando…
The joint action on healthy life years (JA: EHLEIS)
BACKGROUND: Life expectancy has been increasing during the last century within the European Union (EU). To measure progress in population health it is no longer sufficient to focus on the duration of life but quality of life should be considered. Healthy Life Years (HLY) allow estimating the quality...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598905/ https://www.ncbi.nlm.nih.gov/pubmed/23379576 http://dx.doi.org/10.1186/0778-7367-71-2 |
_version_ | 1782262846896209920 |
---|---|
author | Robine, Jean-Marie Cambois, Emmanuelle Nusselder, Wilma Jeune, Bernard Oyen, Herman Van Jagger, Carol |
author_facet | Robine, Jean-Marie Cambois, Emmanuelle Nusselder, Wilma Jeune, Bernard Oyen, Herman Van Jagger, Carol |
author_sort | Robine, Jean-Marie |
collection | PubMed |
description | BACKGROUND: Life expectancy has been increasing during the last century within the European Union (EU). To measure progress in population health it is no longer sufficient to focus on the duration of life but quality of life should be considered. Healthy Life Years (HLY) allow estimating the quality of the remaining years that a person is expected to live, in terms of being free of long-standing activity limitation. The Joint Action on Healthy Life Years (JA: EHLEIS) is a joint action of European Member States (MS) and the European Union aiming at analysing trends, patterns and differences in HLY, as well as in other Summary Measures of Population Health (SMPH) indicators, across the European member states. METHODS: The JA: EHLEIS consolidates existing information on life and health expectancy by maximising the European comparability; by analysing trends in HLY within the EU; by analysing the evolution of the differences in HLY between Member States; and by identifying both macro-level as micro-level determinants of the inequalities in HLY. The JA: EHLEIS works in collaboration with the USA, Japan and OECD on the development of new SMPHs to be used globally. To strengthen the utility of the HLY for policy-making, annual meetings with policy-makers are planned. RESULTS: The information system allows the estimation of a set of health indicators (morbidity and disability prevalence, life and health expectancies) for Europe, Member States and shortly their regional levels. An annual country report on HLY in the national languages is available. The JA: EHLEIS is developing statistical attribution and decomposition tools which will be helpful to determine the impact of specific diseases, life styles or other determinants on differences in HLY. Through a set of international workshops the JA: EHLEIS aims to develop a blueprint for an international harmonized Summary Measure of Population Health. CONCLUSION: The JA: EHLEIS objectives are to monitor progress towards the headline target of the Europe 2020 strategy of increasing HLY by 2 years by 2020 and to support policy development by identifying the main determinants of active and healthy ageing in Europe. |
format | Online Article Text |
id | pubmed-3598905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35989052013-03-17 The joint action on healthy life years (JA: EHLEIS) Robine, Jean-Marie Cambois, Emmanuelle Nusselder, Wilma Jeune, Bernard Oyen, Herman Van Jagger, Carol Arch Public Health Research BACKGROUND: Life expectancy has been increasing during the last century within the European Union (EU). To measure progress in population health it is no longer sufficient to focus on the duration of life but quality of life should be considered. Healthy Life Years (HLY) allow estimating the quality of the remaining years that a person is expected to live, in terms of being free of long-standing activity limitation. The Joint Action on Healthy Life Years (JA: EHLEIS) is a joint action of European Member States (MS) and the European Union aiming at analysing trends, patterns and differences in HLY, as well as in other Summary Measures of Population Health (SMPH) indicators, across the European member states. METHODS: The JA: EHLEIS consolidates existing information on life and health expectancy by maximising the European comparability; by analysing trends in HLY within the EU; by analysing the evolution of the differences in HLY between Member States; and by identifying both macro-level as micro-level determinants of the inequalities in HLY. The JA: EHLEIS works in collaboration with the USA, Japan and OECD on the development of new SMPHs to be used globally. To strengthen the utility of the HLY for policy-making, annual meetings with policy-makers are planned. RESULTS: The information system allows the estimation of a set of health indicators (morbidity and disability prevalence, life and health expectancies) for Europe, Member States and shortly their regional levels. An annual country report on HLY in the national languages is available. The JA: EHLEIS is developing statistical attribution and decomposition tools which will be helpful to determine the impact of specific diseases, life styles or other determinants on differences in HLY. Through a set of international workshops the JA: EHLEIS aims to develop a blueprint for an international harmonized Summary Measure of Population Health. CONCLUSION: The JA: EHLEIS objectives are to monitor progress towards the headline target of the Europe 2020 strategy of increasing HLY by 2 years by 2020 and to support policy development by identifying the main determinants of active and healthy ageing in Europe. BioMed Central 2013-02-04 /pmc/articles/PMC3598905/ /pubmed/23379576 http://dx.doi.org/10.1186/0778-7367-71-2 Text en Copyright © 2013 Robine et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (3http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Robine, Jean-Marie Cambois, Emmanuelle Nusselder, Wilma Jeune, Bernard Oyen, Herman Van Jagger, Carol The joint action on healthy life years (JA: EHLEIS) |
title | The joint action on healthy life years (JA: EHLEIS) |
title_full | The joint action on healthy life years (JA: EHLEIS) |
title_fullStr | The joint action on healthy life years (JA: EHLEIS) |
title_full_unstemmed | The joint action on healthy life years (JA: EHLEIS) |
title_short | The joint action on healthy life years (JA: EHLEIS) |
title_sort | joint action on healthy life years (ja: ehleis) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598905/ https://www.ncbi.nlm.nih.gov/pubmed/23379576 http://dx.doi.org/10.1186/0778-7367-71-2 |
work_keys_str_mv | AT robinejeanmarie thejointactiononhealthylifeyearsjaehleis AT camboisemmanuelle thejointactiononhealthylifeyearsjaehleis AT nusselderwilma thejointactiononhealthylifeyearsjaehleis AT jeunebernard thejointactiononhealthylifeyearsjaehleis AT oyenhermanvan thejointactiononhealthylifeyearsjaehleis AT jaggercarol thejointactiononhealthylifeyearsjaehleis AT robinejeanmarie jointactiononhealthylifeyearsjaehleis AT camboisemmanuelle jointactiononhealthylifeyearsjaehleis AT nusselderwilma jointactiononhealthylifeyearsjaehleis AT jeunebernard jointactiononhealthylifeyearsjaehleis AT oyenhermanvan jointactiononhealthylifeyearsjaehleis AT jaggercarol jointactiononhealthylifeyearsjaehleis |